Oren Gilad Aprea Therapeutics, Inc. (APRE) insider trading activity
Oren Gilad is President/CEO of Aprea Therapeutics, Inc.. Currently has a direct ownership of 345,620 shares of APRE, which is worth approximately $722,345. The most recent transaction as insider was on Apr 03, 2025, when has been sold 5,500 shares (Common Stock) at a price of $1.84 per share, resulting in proceeds of $10,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
346K
3.67%
3M change
4.26%
12M change
Total Value Held
$722,345
Oren Gilad Transaction History
OG
Oren Gilad
President/CEO
Boston, MA